-
By Michael Rubin, MD
Professor of Clinical Neurology at NewYork-Presbyterian Hospital, Cornell Campus
Dr. Rubin is on the speakers bureau for Athena Diagnostics and does research for Pfizer and Merck.
-
By Alan Z. Segal, MD
Assistant Professor, Department of Neurology, Weill Cornell Medical College, and Attending Neurologist at NewYork-Presbyterian Hospital
Dr. Segal is on the speakers bureau of Boehringer-Ingelheim.
Synopsis: There was an increased incidence of injection site reactions among vaccine treated patients, but no difference in the incidence of serious adverse events.
-
Authors: William J. Kennedy, DO, Fellow, Palliative Care Services, Mount Carmel Health, Columbus, OH; Philip H. Santa-Emma, MD, Medical Director, Palliative Care Services, Mount Carmel Health, Columbus, OH; and Robert M. Taylor, MD, Medical Director, Palliative Care Services, Mount Carmel Health, Columbus, OH. Peer Reviewer: Lynn McDonald, MD, Medical Director, Hospice of Kankakee Valley, Bourbonnais, IL.
-
Population-based ovarian cancer screening programs have been difficult to recommend and implement because poor sensitivity and positive predictive value characteristics accompany expensive and inefficient testing methodology and triage algorithms.
-
-
E3N is a French prospective study of cancer risk factorsEtude Epidémiologique de femmes de la Mutuelle Générale de lEduction National. The study population, after exclusions, consists of 54,548 women born between 1925 and 1950, and all belong to a health insurance program that primarily covers teachers.
-
A surprising study recently surfaced in the British Medical Journal. A randomized trial was designed to determine if giving a standard maternal dose of steroids (two injections of 12 mg of betamethasone separated by 24 hours) would decrease the incidence of respiratory distress syndrome (RDS) in infants whose mothers were to have elective Cesarean sections.
-
I missed this article when it first emerged. however, during a recent perinatal conference in California, Dr. Michael Nageotte cited it in an excellent lecture on breeches. Since the report could have an impact in current practice, I am reviewing it in this issue.
-
Ogburn and colleagues report on their experience with adnexal torsion at one university medical center from 1990 to 2001. A chart review identified 68 patients in whom laparoscopic management was accomplished 32% of the time (n = 22) and ovarian conservation in 21% (n = 14).
-
Souka and colleagues have recently published a review that should be very helpful to the clinician confronted with the dilemma of counseling patients whose fetuses have increased nuchal translucencies (NTs) in the first trimester.